Leerink Partners Downgrades Myriad Genetics (MYGN) to Market Perform
Tweet Send to a Friend
(Updated - December 9, 2024 6:26 AM EST)
Leerink Partners analyst Puneet Souda downgraded Myriad Genetics (NASDAQ: MYGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Puneet Souda downgraded Myriad Genetics (NASDAQ: MYGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
